Up a level |
(2018) Bone marrow-mesenchymal stromal cell infusion in patients with chronic kidney disease: A safety study with 18 months of follow-up. Cytotherapy. pp. 660-669. ISSN 1465-3249
(2017) Safety and tolerability of autologous bone marrow mesenchymal stromal cells in ADPKD patients. Stem Cell Research & Therapy. p. 11. ISSN 1757-6512